Limited use of novel psychoactive substances in South London nightclubs.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  QJM : monthly journal of the Association of Physicians

• Publication date

  2012-10-01

• Fields of study

  Medicine, Sociology, Psychology

• Identifiers
  DOI 10.1093/QJMED/HCS107PMID 22718853
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• European Monitoring Centre for Drugs and Drug Addiction

  2014cited by this paper
• ‘Our favourite drug’: prevalence of use and preference for mephedrone in the London night-time economy 1 year after control

  2012cited by this paper
• Mephedrone, “Bubble” and unidentified white powders : the contested identities of synthetic “legal highs”

  2011cited by this paper
• The rise in legal highs: prevalence and patterns in the use of illegal drugs and first- and second-generation “legal highs” in South London gay dance clubs

  2011cited by this paper
• Tactical dangers: findings from the United Kingdom Gay Men's Sex Survey 2008.

  2010cited by this paper
• Our favourite drug

  2002cited by this paper

• Prevalence of Novel Psychoactive Substance (NPS) Use Across Different Geographical Regions of the World: A Systematic Review and Meta-Analysis

  2026influential citation
• Barriers to uptake of harm reduction techniques for GBMSM who use drugs in night-clubs and sex-on-premises venues in London and the Southeast: a mixed-methods, qualitative study

  2025cites this paper
• Characterising differences between self-reported and wastewater-identified drug use at two consecutive years of an Australian music festival.

  2024cites this paper
• Analysing the use trends of new psychoactive substances using wastewater-based epidemiology in Europe: A systematic review

  2023cites this paper
• Social issues in the use of new psychoactive substances: Differentiated demand, displacement and adulteration

  2022cites this paper
• The Novel Psychoactive Substances Epidemic: a Scientometric Perspective

  2022cites this paper
• Novel detection methods and data triangulation for novel psychoactive substances (NPS)

  2022cites this paper
• Prevalence of use of novel psychoactive substances

  2022cites this paper
• Knowledge and Use of Novel Psychoactive Substances in Italy: a Survey-Based Study in the General Population

  2021cites this paper
• Impact of the UK Psychoactive Substances Act on awareness, use, experiences and knowledge of potential associated health risks of Novel Psychoactive Substances.

  2020cites this paper
• Polysubstance use patterns and novel synthetics: A cluster analysis from three U.S. cities

  2019cites this paper
• The synthetic cathinone psychostimulant α-PPP antagonizes serotonin 5-HT2A receptors: In vitro and in vivo evidence.

  2019cites this paper
• How and Where to Find NPS Users: a Comparison of Methods in a Cross-National Survey Among Three Groups of Current Users of New Psychoactive Substances in Europe

  2019cites this paper
• Methoxetamine: A foe or friend?

  2019cites this paper
• Karakteristike konzumenata novih psihoaktivnih tvari

  2019cites this paper
• Deaths in the Lesbian, Gay, Bisexual and Transgender United Kingdom Communities Associated with GHB and Precursors.

  2018cites this paper
• Synthetic Cathinones

  2018cites this paper
• The Effects and Risks Associated with Synthetic Cathinones Use in Humans

  2018cites this paper
• Diffusion of New Psychoactive Substances: understanding population motives, harms and intervention needs

  2018cites this paper
• Synthetic Cathinones—Prevalence and Motivations for Use

  2018cites this paper
• The diverse reasons for using Novel Psychoactive Substances - A qualitative study of the users' own perspectives.

  2018cites this paper
• 'I quit heroin for meow' : a qualitative study of the use of new psychoactive substances among problem drug users in South Wales

  2018cites this paper
• Neue psychoaktive Substanzen: Konsummuster, Konsummotive, Nebenwirkungen und problematischer Konsum

  2018cites this paper
• Effects of the second-generation "bath salt" cathinone alpha-pyrrolidinopropiophenone (α-PPP) on behavior and monoamine neurochemistry in male mice

  2018cites this paper
• Analysis of the Bases of Power of Key Players in the Industry of Novel Psychoactive Substances

  2017cites this paper
• The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations.

  2017cites this paper
• Challenges Posed by Novel Psychoactive Substances – Middle East Perspective

  2017cites this paper
• Characteristics of NPS use in patients admitted to acute psychiatric services in Southeast Scotland: a retrospective cross-sectional analysis following public health interventions

  2017cites this paper
• Novel Psychoactive Substances

  2017cites this paper
• Monitoring risk behaviour in adolescent pupils regarding consumption of psychoactive substances.

  2017cites this paper
• Synthetic cathinones in Southern Germany – characteristics of users, substance-patterns, co-ingestions, and complications

  2017cites this paper
• A comparison of recreational drug use amongst sexual health clinic users in London with existing prevalence data

  2016cites this paper
• The "legal highs" of novel drugs of abuse

  2016cites this paper
• Prevalence of Use of Electronic Nicotine Delivery Systems (ENDS) to Vape Recreational Drugs by Club Patrons in South London

  2016cites this paper
• Methoxetamine, a novel psychoactive substance with serious adverse pharmacological effects: a review of case reports and preclinical findings

  2016influential citation
• International trends in spice use: Prevalence, motivation for use, relationship to other substances, and perception of use and safety for synthetic cannabinoids.

  2016cites this paper
• Self-reported use of novel psychoactive substances among attendees of electronic dance music venues

  2016cites this paper
• Novel psychoactive substances: An investigation of temporal trends in social media and electronic health records

  2016influential citation
• eview he effects and risks associated to mephedrone and methylone in umans : A review of the preliminary evidences

  2016cites this paper
• Epidemiology of adolescent substance use in London schools.

  2016cites this paper
• [Use of psychostimulants in a sexual context: Analysis of cases reported to the French network of Addictovigilance Centers].

  2016cites this paper
• Mephedrone and 3,4-methylenedioxy-methamphetamine: Comparative psychobiological effects as reported by recreational polydrug users

  2016cites this paper
• Methoxetamine: An early report on the motivations for use, effect profile and prevalence of use in a UK clubbing sample.

  2016cites this paper
• The users of Novel Psychoactive Substances: Online survey about their characteristics, attitudes and motivations.

  2016cites this paper
• Chromatographic analysis and survey studies to evaluate the emerging drugs of synthetic cannabinoids in Scotland and Saudi Arabia

  2016cites this paper
• Impurity profiling of illicit drugs

  2016cites this paper
• What’s so 'new’ about new psychoactive substances? Definitions, prevalence, motivations, user groups and a proposed new taxonomy.

  2016cites this paper
• [Cathinones use in Paris].

  2016cites this paper
• Arylcyclohexamines: Ketamine, Phencyclidine, and Analogues

  2016cites this paper
• Usage de psychostimulants dans un contexte sexuel : analyse des cas rapportés au Réseau français des centres d’addictovigilance. Évaluation des risques liés à la pratique du SLAM ☆

  2016cites this paper
• The effects and risks associated to mephedrone and methylone in humans: A review of the preliminary evidences.

  2016cites this paper
• Adding Spice to the Porridge: The development of a synthetic cannabinoid market in an English prison.

  2016cites this paper
• Markets and Distribution Systems

  2015cites this paper
• Is there any difference in patterns of use and psychiatric symptom status between injectors and non‐injectors of mephedrone?

  2015cites this paper
• Prevalence of use and acute toxicity associated with the use of NBOMe drugs

  2015cites this paper
• A novel psychoactive substance poses a new challenge in the management of paranoid schizophrenia

  2015cites this paper
• Pharmacology and toxicology of the synthetic cannabinoid receptor agonists

  2015cites this paper
• Analysis of anonymized pooled urine in nine UK cities: variation in classical recreational drug, novel psychoactive substance and anabolic steroid use.

  2015cites this paper
• Problematic recreational drug use: is there a role for outpatient sexual health clinics in identifying those not already engaged with treatment services?

  2015cites this paper
• Drogas emergentes: catinonas sintéticas ('sales de baño')

  2015cites this paper
• Acute recreational drug and new psychoactive substance toxicity in Europe: 12 months data collection from the European Drug Emergencies Network (Euro-DEN)

  2015cites this paper
• Synthetic Cathinones: A New Public Health Problem

  2015cites this paper
• Ketamine—Epidemiology of misuse and patterns of acute and chronic toxicity

  2015cites this paper
• Poisoning Casualties: Alcohol, Pharmaceuticals or Legal Highs Poisoning Cases at Emergency Rooms in The Swedish County Vrmland in 2007-2013

  2015cites this paper
• “Chasing the High” – Experiences of Ethylphenidate as Described on International Internet Forums

  2015cites this paper
• Metoksetamina – nowy związek psychoaktywny („dopalacz”) o silnym działaniu psychodysleptycznym

  2015cites this paper
• Pharmacology and Toxicology of the Synthetic Cannabinoid Receptor Agonists Pharmacologie et toxicologie des agonistes synthétiques des récepteurs cannabinoïdes

  2015cites this paper
• Deaths of individuals aged 16–24 years in the UK after using mephedrone

  2015cites this paper
• Guidance on the clinical management of acute and chronic harms of club drugs and novel psychoactive substances.

  2015cites this paper
• The Ketamine Analog Methoxetamine: A New Designer Drug to Threaten Military Readiness Capt Cassandra L. Craig, USAF MC*; LT George H. Loeffler, MC USN†

  2014cites this paper
• Methoxetamine--a novel recreational drug with potent hallucinogenic properties.

  2014influential citation
• Methoxetamine: prevalence of use in the USA and UK and associated urinary problems

  2014influential citation
• Using poisons information service data to assess the acute harms associated with novel psychoactive substances.

  2014cites this paper
• The ketamine analog methoxetamine: a new designer drug to threaten military readiness.

  2014cites this paper
• A Guide to the Extrapyramidal Side-Effects of Antipsychotic Drugs by D. G. Cunningham Owens

  2014cites this paper
• New psychoactive substances in England: a review of the evidence.

  2014cites this paper
• Retrospective analysis of synthetic cannabinoids in serum samples--epidemiology and consumption patterns.

  2014cites this paper
• NEW PSYCHOACTIVE SUBSTANCES - EVIDENCE REVIEW

  2014cites this paper
• Mephedrone, assassin of youth: The rhetoric of fear in contemporary drug scares

  2014cites this paper
• Addiction aux drogues stimulantes (cocaïne, méthamphétamine et nouveaux produits de synthèse)

  2014cites this paper
• The preclinical pharmacology of mephedrone; not just MDMA by another name

  2014cites this paper
• “Spice,” “Kryptonite,” “Black Mamba”: An Overview of Brand Names and Marketing Strategies of Novel Psychoactive Substances on the Web

  2014cites this paper
• Risk assessment of GBL as a substitute for the illicit drug GHB in the Netherlands. A comparison of the risks of GBL versus GHB.

  2014cites this paper
• Bath salts and synthetic cathinones: an emerging designer drug phenomenon.

  2014cites this paper
• Elements: in this month's issue.

  2014cites this paper
• Substance Use in the Club Scene of Rome: A Pilot Study

  2014cites this paper
• Recreational drug use in men who have sex with men (MSM) attending UK sexual health services is significantly higher than in non-MSM

  2014cites this paper
• Trend analysis of anonymised pooled urine from portable street urinals in central London identifies variation in the use of novel psychoactive substances

  2014cites this paper
• Three months of methoxetamine administration is associated with significant bladder and renal toxicity in mice

  2014cites this paper
• Designer cathinones--an emerging class of novel recreational drugs.

  2013cites this paper
• Synthetic Cannabinoids and Cathinones: Prevalence and Markets.

  2013cites this paper
• MDAI (5,6‐methylenedioxy‐2‐aminoindane; 6,7‐dihydro‐5H‐cyclopenta[f][1,3]benzodioxol‐6‐amine; ‘sparkle’; ‘mindy’) toxicity: a brief overview and update

  2013influential citation
• Differential effects of cathinone compounds and MDMA on body temperature in the rat, and pharmacological characterization of mephedrone‐induced hypothermia

  2013cites this paper
• Monitoring trends in recreational drug use from the analysis of the contents of amnesty bins in gay dance clubs.

  2013cites this paper
• Social Issues in the Use of Novel Psychoactive Substances: Differentiated Demand and Ideological Supply

  2013cites this paper
• Intoxication non létale par la Méthoxétamine : confirmation analytique à l’aide d’un système d’extraction en ligne Turboflow® couplé à de la LC/MS/MS

  2013cites this paper
• Synthetic Cannabinoid Receptor Agonists

  2013cites this paper
• Monitoring Novel Psychoactive Substances: A Global Perspective

  2013cites this paper
• Increases in use of novel synthetic stimulant are not directly linked to decreased use of 3,4-methylenedioxy-N-methylamphetamine (MDMA).

  2013cites this paper
• Epidemiology of Use of Novel Psychoactive Substances

  2013cites this paper